ApprovalTrail

Approval · Notice of Compliance 21075 · 2018

PANHEMATIN: Notice of Compliance 21075

Issued July 13, 2018

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
21075
Date
July 13, 2018
Company
Recordati Rare Diseases Canada IncToronto, Ontario, Canada
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
Priority-NAS

Products in this notice

BrandDINStatus today
PANHEMATIN02478765Marketed

Medicinal ingredients